by admin | Jul 24, 2024 | iSCIB1+, Latest News, Regulatory News, SCIB1
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! by admin | Jun 18, 2024 | Interviews, Latest News, Media Coverage, Modi-1, SCIB1
Scancell founder says the company is ready to commercialise novel medicines to counteract cancer Scancell’s Chief Executive Officer, Lindy Durrant, recently sat down with Sarah Lowther from focusIR. During the interview Lindy highlights Scancell’s innovative... by chantal | Jun 11, 2024 | Modi-1, SCIB1, Vaccines
21st Association for Cancer Immunotherapy (CIMT) Annual Meeting, Mainz, May 2024 A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma Samantha Paston, Heather Shaw, Poulam Patel, Miranda... by admin | May 30, 2024 | Latest News, Modi-1, Regulatory News
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! by admin | Apr 17, 2024 | Immunobody, Latest News, Modi-1, Regulatory News, SCIB1
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! by admin | Apr 4, 2024 | Latest News, Regulatory News, SCIB1
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!